ID: ALA2303732

Max Phase: Preclinical

Molecular Formula: C24H30BrNO11

Molecular Weight: 588.40

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(=O)N[C@@H]1[C@H](Oc2ccc3cc(Br)ccc3c2)O[C@@H](CO)[C@@H](O[C@@H]2O[C@@H](CO)[C@H](O)[C@H](O)[C@@H]2O)[C@@H]1O

Standard InChI:  InChI=1S/C24H30BrNO11/c1-10(29)26-17-19(31)22(37-24-21(33)20(32)18(30)15(8-27)35-24)16(9-28)36-23(17)34-14-5-3-11-6-13(25)4-2-12(11)7-14/h2-7,15-24,27-28,30-33H,8-9H2,1H3,(H,26,29)/t15-,16-,17-,18-,19+,20-,21-,22+,23+,24-/m0/s1

Standard InChI Key:  BRFDZKHHLNQIBD-MBQUBCGXSA-N

Associated Targets(non-human)

Beta-1,4-galactosyltransferase 1 61 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

N-acetyllactosaminide alpha-1,3-galactosyltransferase 11 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 588.40Molecular Weight (Monoisotopic): 587.1002AlogP: -1.25#Rotatable Bonds: 7
Polar Surface Area: 187.40Molecular Species: NEUTRALHBA: 11HBD: 7
#RO5 Violations: 3HBA (Lipinski): 12HBD (Lipinski): 7#RO5 Violations (Lipinski): 3
CX Acidic pKa: 11.79CX Basic pKa: CX LogP: -0.90CX LogD: -0.90
Aromatic Rings: 2Heavy Atoms: 37QED Weighted: 0.20Np Likeness Score: 1.00

References

1. Chung SJ, Takayama S, Wong CH..  (1998)  Acceptor substrate-based selective inhibition of galactosyltransferases.,  (23): [PMID:9873734] [10.1016/s0960-894x(98)00618-0]

Source